These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 14585520)

  • 1. Dose proportionality study of four doses of an estradiol transdermal system, Estradot.
    Hossain M; Quebe-Fehling E; Sergejew T; Schmidt G; Skerjanec A; Ibarra de Palacios P; Krinsky L
    Maturitas; 2003 Nov; 46(3):173-85. PubMed ID: 14585520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative bioequivalence studies with Estradot and Menorest transdermal systems.
    Hossain M; Quebe-Fehling E; Sergejew T; Schmidt G; Skerjanec A; Cohen A; Krinsky L; Ibarra de Palacios P
    Maturitas; 2003 Nov; 46(3):187-98. PubMed ID: 14585521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study to evaluate skin irritation and adhesion of Estradot and Climara in healthy postmenopausal women.
    Ibarra de Palacios P; Schmidt G; Sergejew T; Quebe-Fehling E; Lockhart L; Krinsky L
    Climacteric; 2002 Dec; 5(4):383-9. PubMed ID: 12626218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of irritation and sensitisation of two 50 microg/day oestrogen patches.
    Toole J; Silagy S; Maric A; Fath B; Quebe-Fehling E; Ibarra de Palacios P; Laurin L; Giguere M
    Maturitas; 2002 Dec; 43(4):257-63. PubMed ID: 12468134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol and estrone plasma levels during application of three strengths of a 7-day estradiol transdermal patch.
    Setnikar I; Rovati LC; Santoro A; Guillaume M; Mignot A; Renoux A; Gualano V
    Arzneimittelforschung; 1999 Aug; 49(8):708-15. PubMed ID: 10483519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of estradiol and of estrone during application of a new 7-day estradiol transdermal patch with active matrix.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1998 Mar; 48(3):275-85. PubMed ID: 9553686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 17Beta-estradiol delivered by three different matrix patches 50 microg/day: a three way cross-over study in 21 postmenopausal women.
    Rohr UD; Nauert C; Stehle B
    Maturitas; 1999 Sep; 33(1):45-58. PubMed ID: 10585173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with a seven-day estradiol transdermal system for estrogen replacement therapy.
    Gordon SF
    Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 2):998-1004. PubMed ID: 7573298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma profiles of transdermal 17 beta-estradiol delivered by two different matrix patches. A four-way cross-over study in postmenopausal women.
    Rohr UD; Ehrly AM; Kuhl H
    Arzneimittelforschung; 1997 Jun; 47(6):761-7. PubMed ID: 9239456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of a 7 day 17 beta-estradiol transdermal delivery system: pharmacokinetics in healthy postmenopausal women.
    Boyd RA; Zegarac EA; Eldon MA; Sedman AJ; Forgue ST
    Biopharm Drug Dispos; 1996 Aug; 17(6):459-70. PubMed ID: 8866037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of estradiol and of estrone during application of three strengths of an estradiol transdermal patch with active matrix.
    Setnikar I; Rovati LC; Thebault JJ; Guillaume M; Mignot A; Renoux A; Gualano V
    Arzneimittelforschung; 1997 Jul; 47(7):859-65. PubMed ID: 9272245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative bioavailability study of an once-a-week matrix versus a twice-a-week reservoir transdermal estradiol delivery systems in postmenopausal women.
    Baracat E; Haidar M; Castelo A; Tufik S; de Lima GR; Vieira JG; Peloso U; Casoy J
    Maturitas; 1996 Apr; 23(3):285-91. PubMed ID: 8794422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and tolerability of Estraderm MX, a new estradiol matrix patch.
    Bacchi-Modena A; Bolis P; Campagnoli C; De Cicco F; Meschia M; Pansini F; Pisati R; Hüls G
    Maturitas; 1997 Jul; 27(3):285-92. PubMed ID: 9288701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An evaluation of bioequivalence of two 7-day 17beta-estradiol transdermal delivery systems by anatomical site.
    Harrison LL; Harari D
    J Clin Pharmacol; 2002 Oct; 42(10):1134-41. PubMed ID: 12362928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17beta-estradiol matrixpatch removal and reapplication in postmenopausal women: experimental results.
    Rohr UD; Saeger-Lorenz K
    J Pharm Sci; 2002 Mar; 91(3):810-21. PubMed ID: 11920767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of Fem7, a once-weekly, transdermal oestrogen replacement system in healthy, postmenopausal women.
    Geyer D; Gerrits MG; Renoux A; Uhl W
    Gynecol Obstet Invest; 1999; 48(1):1-6. PubMed ID: 10394083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steady-state pharmacokinetics following application of a novel transdermal estradiol spray in healthy postmenopausal women.
    Morton TL; Gattermeir DJ; Petersen CA; Day WW; Schumacher RJ
    J Clin Pharmacol; 2009 Sep; 49(9):1037-46. PubMed ID: 19628730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative absorption and variability in absorption of estradiol from a transdermal gel and a novel matrix-type transdermal patch.
    Järvinen A; Bäckström A; Elfström C; Viitanen A
    Maturitas; 2001 Apr; 38(2):189-96. PubMed ID: 11306208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of estradiol and of estrone during repeated transdermal or oral administration of estradiol.
    Setnikar I; Rovati LC; Vens-Cappell B; Hilgenstock C
    Arzneimittelforschung; 1996 Aug; 46(8):766-73. PubMed ID: 9125276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS; Donath F; Blume HH
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.